All Title Author
Keywords Abstract

PLOS Medicine  2008 

Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies

DOI: 10.1371/journal.pmed.0050152

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Several studies have suggested that diabetes mellitus (DM) increases the risk of active tuberculosis (TB). The rising prevalence of DM in TB-endemic areas may adversely affect TB control. We conducted a systematic review and a meta-analysis of observational studies assessing the association of DM and TB in order to summarize the existing evidence and to assess methodological quality of the studies. Methods and Findings We searched the PubMed and EMBASE databases to identify observational studies that had reported an age-adjusted quantitative estimate of the association between DM and active TB disease. The search yielded 13 observational studies (n = 1,786,212 participants) with 17,698 TB cases. Random effects meta-analysis of cohort studies showed that DM was associated with an increased risk of TB (relative risk = 3.11, 95% CI 2.27–4.26). Case-control studies were heterogeneous and odds ratios ranged from 1.16 to 7.83. Subgroup analyses showed that effect estimates were higher in non-North American studies. Conclusion DM was associated with an increased risk of TB regardless of study design and population. People with DM may be important targets for interventions such as active case finding and treatment of latent TB and efforts to diagnose, detect, and treat DM may have a beneficial impact on TB control.

References

[1]  World Health Organization (2007) Tuberculosis Fact Sheet. Fact Sheet No. 104. Available: http://www.who.int/mediacentre/factsheet?s/fs104/en/print.html. Accessed 25 September 2007.
[2]  Banyai A (1931) Diabetes and pulmonary tuberculosis. Am Rev Tuberc 24: 650–667.
[3]  Root H (1934) The association of diabetes and tuberculosis. New Engl J Med 210: 1–13.
[4]  Boucot KR, Dillon ES, Cooper DA, Meier P, Richardson R (1952) Tuberculosis among diabetics: the Philadelphia survey. Am Rev Tuberc 65: 1–50.
[5]  Nichols GP (1957) Diabetes among young tuberculous patients; a review of the association of the two diseases. Am Rev Tuberc 76: 1016–1030.
[6]  Silwer H, Oscarsson PN (1958) Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county. Acta Med Scand Suppl 335: 1–48.
[7]  Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG (1995) Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 76: 529–533.
[8]  Pablos-Mendez A, Blustein J, Knirsch CA (1997) The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 87: 574–579.
[9]  Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, et al. (2004) Tuberculosis and diabetes in southern Mexico. Diabetes Care 27: 1584–1590.
[10]  Alisjahbana B, van Crevel R, Sahiratmadja E, den Heijer M, Maya A, et al. (2006) Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 10: 696–700.
[11]  Perez A, Brown HS 3rd, Restrepo BI (2006) Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. Am J Trop Med Hyg 74: 604–611.
[12]  Oluboyo PO, Erasmus RT (1990) The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 71: 135–138.
[13]  Basoglu OK, Bacakoglu F, Cok G, Sayiner A, Ates M (1999) The oral glucose tolerance test in patients with respiratory infections. Monaldi Arch Chest Dis 54: 307–310.
[14]  World Health Organization (2006) Diabetes fact sheet No. 312. Available: http://www.who.int/mediacentre/factsheet?s/fs312/en/index.html. Accessed 12 March 2008.
[15]  Restrepo BI (2007) Convergence of the tuberculosis and diabetes epidemics: Renewal of old acquaintances. Clin Inf Dis 45: 436–438.
[16]  Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, et al. (2007) DM and tuberculosis: the impact of the DM epidemic on tuberculosis incidence. BMC Public Health 7: 234.
[17]  Dixon B (2007) Diabetes and tuberculosis: an unhealthy partnership. Lancet Infect Dis 7: 444.
[18]  Wild S, Sicree R, Roglic G, King H, Green A (2004) Global prevalence of diabetes: Estimates for the year 200 and projections for 2030. Diabetes Care 27: 1047–1053.
[19]  WHO (2007) Global tuberculosis control: surveillance, planning, financing. WHO report 2007. WHO/HTM/TB/2007.376. Geneva: WHO. Available: http://www.who.int/tb/publications/globa?l_report/2007/en/index.html. Accessed 10 June 2008.
[20]  Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA 283: 2008–2012.
[21]  Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10: 101–129.
[22]  Higgins JP, Thompson SG (2002) Quantifying heterogeneity in meta-analyses. Stat Med 21: 1539–1558.
[23]  DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177–188.
[24]  Greenland S, Thomas DC (1982) On the need for the rare disease assumption in case-control studies. Am J Epidemiol 116: 547–553.
[25]  Dyck RF, Klomp H, Marciniuk DD, Tan L, Stang MR, et al. (2007) The relationship between diabetes and tuberculosis in Saskatchewan. Can J Public Health 98: 55–59.
[26]  Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088–1101.
[27]  Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–634.
[28]  R Development Core Team (2007) R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. Available: http://www.R-project.org.
[29]  StataCorp (2007) Stata Statistical Software: Release 10. College Station (Texas): StataCorp LP.
[30]  Chen CH, Lian JD, Cheng CH, Wu MJ, Lee WC, et al. (2006) infection following renal transplantation in Taiwan. Transpl Infect Dis 8: 148–156.
[31]  Brassard P, Kezouh A, Suissa S (2006) Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 43: 717–722.
[32]  John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, et al. (2001) Risk factors for post-transplant tuberculosis. Kidney Int 60: 1148–1153.
[33]  Jick SS, Lieberman ES, Rahman MU, Choi HK (2006) Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 55: 19–26.
[34]  Mori MA, Leonardson G, Welty TK (1992) The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians. Arch Intern Med 152: 547–550.
[35]  Buskin SE, Gale JL, Weiss NS, Nolan CM (1994) Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990. Am J Public Health 84: 1750–1756.
[36]  Rosenman KD, Hall N (1996) Occupational risk factors for developing tuberculosis. Am J Ind Med 30: 148–154.
[37]  Coker R, McKee M, Atun R, Dimitrova B, Dodonova E, et al. (2006) Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 332: 85–87.
[38]  Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, et al. (2005) Investigation of the risk factors for tuberculosis: A case-control study in three countries in West Africa. Int J Epidemiol 34: 914–923.
[39]  Mugusi F, Swai AB, Alberti KG, McLarty DG (1990) Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 71: 271–276.
[40]  Abe T, Iinuma Y, Ando M, Yokoyama T, Yamamoto T, et al. (2003) NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis. J Infect 46: 215–220.
[41]  Al Kubaisy W, Al Dulayme A, Hashim DS (2003) Active tuberculosis among Iraqi schoolchildren with positive skin tests and their household contacts. East Mediterr Health J 9: 675–688.
[42]  Tocque K, Bellis MA, Beeching NJ, Syed Q, Remmington T, et al. (2001) A case-control study of lifestyle risk factors associated with tuberculosis in Liverpool, North-West England. Eur Respir J 18: 959–964.
[43]  Stevenson CR, Critchley JA, Forouhi NG, Roglic G, Williams BG, et al. (2007) Diabetes and the risk of tuberculosis: a neglected threat to public health. Chronic Illn 3: 228–245.
[44]  World Health Organization (2000) WHO Global InfoBase. Mexico Encuesta Nacional de Salud 2000: tomo 2 la salud de los adultos. Available: http://www.who.int/infobase/reportviewer?.aspx?rptcode=ALL&uncode=484&dm=2&survey?code=101056a1. Accessed 12 March 2008.
[45]  Lienhardt C, Rodrigues LC (1997) Estimation of the impact of the human immunodeficiency virus infection on tuberculosis: tuberculosis risks re-visited. Int J Tuberc Lung Dis 1: 196–204.
[46]  UNAIDS (2007) AIDS epidemic update 2007. UNAIDS/07.27E / JC1322E. Available: http://data.unaids.org/pub/EPISlides/200?7/2007_epiupdate_en.pdf. Accessed 12 March 2008.
[47]  Yamashiro S, Kwakami K, Uezu K, Kinjo T, Miyagi K, et al. (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with . Clin Exp Immunol 139: 57–64.
[48]  Martens GW, Arikan MC, Lee J, Ren F, Greiner D, et al. (2007) Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol 37: 518–524.
[49]  Viardot A, Grey ST, Mackay F, Chisholm D (2007) Potential anti-inflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148: 346–353.
[50]  Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff THM, et al. (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27: 97–103.
[51]  Tsukaguchi K, Okamura H, Ikuno M, Kobayashi A, Fukuoka A, et al. (1997) [The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis]. Kekkaku 72: 617–622.
[52]  Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, et al. (1997) Impaired Leucocyte functions in diabetic patients. Diabet Med 14: 29–34.
[53]  Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, et al. (1982) Infection and diabetes: The case for glucose control. Am J Med 72: 439–450.
[54]  Feinstein AR, Walter SD, Horwitz RI (1986) An analysis of Berkson's bias in case-control studies. J Chron Dis 39: 495–504.
[55]  Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, et al. (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21: 518–524.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

微信:OALib Journal